SCHEMBL19397472

SCHEMBL19397472

CC1(C)c2ccccc2-c2cccc(-c3cccc(-c4cc(-c5ccc(-c6ccccc6)cc5)nc(-c5ccc(-c6ccncc6)cc5)n4)c3)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.41
KMT2A Q03164 8/20 0.41
MAPT P10636 8/20 0.41
ALDH1A1 P00352 7/20 0.41
HPGD P15428 5/20 0.41
KDM4E B2RXH2 4/20 0.41
LMNA P02545 3/20 0.41
GLA P06280 1/20 0.41
PDK2 Q15119 1/20 0.40
NTSR1 P30989 1/20 0.40
NPSR1 Q6W5P4 2/20 0.38
RECQL P46063 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397429 1.00 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19397586 0.95 PDK2 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19397543 0.95 PDK2 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19397312 0.95 MAPT (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19397359 0.95 MAPT (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25008644 0.93 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25009285 0.93 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25008645 0.93 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17887182 0.93 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25008508 0.93 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM MEN1 682/4885KMT2A 3347/4885MAPT 3242/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 MEN1 509/4885KMT2A 3322/4885MAPT 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.